The biology that explains the association of APOL1 variants with nondiabetic kidney diseases in black patients remains controversial.Many, but not all, studies suggest that APOL1 variant-dependent cytotoxicity is associated with kidney diseases (also reviewed in Ref.[1-4]). Furthermore, animal models have linked changes in podocyte number with APOL1 genotype. We previously demonstrated podocyte depletion in transgenic mice constitutively expressing the G2 variant of APOL1 in podocytes under the Nephrin promoter (Nphs1. APOL1-G2), but not in wild type or APOL1-G0 expressing (Nphs1. APOL1-G0) mice, despite normal biochemical and histologic kidney phenotypes. 5 Mice with HIV-associated nephropathy (HIVAN) and transgenic for Nphs1.APOL-G0 had preserved podocyte numbers and densities; whereas, HIVAN mice with Nphs1.APOL1-G2 had podocyte numbers and density similar to HIVAN only mice. 6 The podocyte depletion hypothesis proposes that the progressive podocyte loss occurs with physiological stress of aging but only results